Barbara Cangemi

Suggest Changes
Learn More
AIM Considerable controversy surrounds mortality from non-neoplastic diseases during the postoperative follow-up of patients with non-small cell lung cancer (NSCLC) and chronic obstructive pulmonary(More)
  • 1